vs

Side-by-side financial comparison of Solventum (SOLV) and Toast, Inc. (TOST). Click either name above to swap in a different company.

Solventum is the larger business by last-quarter revenue ($2.0B vs $1.6B, roughly 1.2× Toast, Inc.). Toast, Inc. runs the higher net margin — 6.2% vs 3.2%, a 3.0% gap on every dollar of revenue. On growth, Toast, Inc. posted the faster year-over-year revenue change (22.0% vs -3.7%). Toast, Inc. produced more free cash flow last quarter ($178.0M vs $32.0M). Over the past eight quarters, Toast, Inc.'s revenue compounded faster (23.3% CAGR vs -0.4%).

Solventum Corporation is an American health care company that was spun off from 3M on April 1, 2024.

Toast, Inc. is an American cloud-based restaurant management software company based in Boston, Massachusetts. The company provides an all-in-one point of sale (POS) system built on the Android operating system.

SOLV vs TOST — Head-to-Head

Bigger by revenue
SOLV
SOLV
1.2× larger
SOLV
$2.0B
$1.6B
TOST
Growing faster (revenue YoY)
TOST
TOST
+25.8% gap
TOST
22.0%
-3.7%
SOLV
Higher net margin
TOST
TOST
3.0% more per $
TOST
6.2%
3.2%
SOLV
More free cash flow
TOST
TOST
$146.0M more FCF
TOST
$178.0M
$32.0M
SOLV
Faster 2-yr revenue CAGR
TOST
TOST
Annualised
TOST
23.3%
-0.4%
SOLV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
SOLV
SOLV
TOST
TOST
Revenue
$2.0B
$1.6B
Net Profit
$63.0M
$101.0M
Gross Margin
51.4%
25.9%
Operating Margin
6.3%
5.2%
Net Margin
3.2%
6.2%
Revenue YoY
-3.7%
22.0%
Net Profit YoY
103.2%
215.6%
EPS (diluted)
$0.37
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SOLV
SOLV
TOST
TOST
Q4 25
$2.0B
$1.6B
Q3 25
$2.1B
$1.6B
Q2 25
$2.2B
$1.6B
Q1 25
$2.1B
$1.3B
Q4 24
$2.1B
$1.3B
Q3 24
$2.1B
$1.3B
Q2 24
$2.1B
$1.2B
Q1 24
$2.0B
$1.1B
Net Profit
SOLV
SOLV
TOST
TOST
Q4 25
$63.0M
$101.0M
Q3 25
$1.3B
$105.0M
Q2 25
$90.0M
$80.0M
Q1 25
$137.0M
$56.0M
Q4 24
$31.0M
$32.0M
Q3 24
$122.0M
$56.0M
Q2 24
$89.0M
$14.0M
Q1 24
$237.0M
$-83.0M
Gross Margin
SOLV
SOLV
TOST
TOST
Q4 25
51.4%
25.9%
Q3 25
54.2%
26.5%
Q2 25
54.4%
25.3%
Q1 25
53.8%
25.9%
Q4 24
53.9%
24.9%
Q3 24
56.0%
24.7%
Q2 24
54.6%
23.0%
Q1 24
58.1%
23.2%
Operating Margin
SOLV
SOLV
TOST
TOST
Q4 25
6.3%
5.2%
Q3 25
80.6%
5.1%
Q2 25
9.9%
5.2%
Q1 25
7.3%
3.2%
Q4 24
6.6%
2.5%
Q3 24
13.2%
2.6%
Q2 24
11.7%
0.4%
Q1 24
18.9%
-5.2%
Net Margin
SOLV
SOLV
TOST
TOST
Q4 25
3.2%
6.2%
Q3 25
60.4%
6.4%
Q2 25
4.2%
5.2%
Q1 25
6.6%
4.2%
Q4 24
1.5%
2.4%
Q3 24
5.9%
4.3%
Q2 24
4.3%
1.1%
Q1 24
11.8%
-7.7%
EPS (diluted)
SOLV
SOLV
TOST
TOST
Q4 25
$0.37
$0.18
Q3 25
$7.22
$0.16
Q2 25
$0.51
$0.13
Q1 25
$0.78
$0.09
Q4 24
$0.18
$0.09
Q3 24
$0.70
$0.07
Q2 24
$0.51
$0.02
Q1 24
$1.37
$-0.15

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SOLV
SOLV
TOST
TOST
Cash + ST InvestmentsLiquidity on hand
$878.0M
$1.4B
Total DebtLower is stronger
$5.0B
Stockholders' EquityBook value
$5.0B
$2.1B
Total Assets
$14.3B
$3.1B
Debt / EquityLower = less leverage
1.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SOLV
SOLV
TOST
TOST
Q4 25
$878.0M
$1.4B
Q3 25
$1.6B
$1.4B
Q2 25
$492.0M
$1.2B
Q1 25
$534.0M
$1.0B
Q4 24
$762.0M
$903.0M
Q3 24
$772.0M
$761.0M
Q2 24
$897.0M
$691.0M
Q1 24
$996.0M
$578.0M
Total Debt
SOLV
SOLV
TOST
TOST
Q4 25
$5.0B
Q3 25
$5.1B
Q2 25
$7.8B
Q1 25
$7.9B
Q4 24
$8.0B
Q3 24
$8.1B
Q2 24
$8.3B
Q1 24
$8.3B
Stockholders' Equity
SOLV
SOLV
TOST
TOST
Q4 25
$5.0B
$2.1B
Q3 25
$5.0B
$2.0B
Q2 25
$3.6B
$1.8B
Q1 25
$3.3B
$1.7B
Q4 24
$3.0B
$1.5B
Q3 24
$3.2B
$1.4B
Q2 24
$2.9B
$1.3B
Q1 24
$3.9B
$1.2B
Total Assets
SOLV
SOLV
TOST
TOST
Q4 25
$14.3B
$3.1B
Q3 25
$14.0B
$3.0B
Q2 25
$15.1B
$2.8B
Q1 25
$14.5B
$2.6B
Q4 24
$14.5B
$2.4B
Q3 24
$14.7B
$2.2B
Q2 24
$14.6B
$2.2B
Q1 24
$14.7B
$2.1B
Debt / Equity
SOLV
SOLV
TOST
TOST
Q4 25
1.00×
Q3 25
1.03×
Q2 25
2.14×
Q1 25
2.43×
Q4 24
2.71×
Q3 24
2.54×
Q2 24
2.90×
Q1 24
2.16×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SOLV
SOLV
TOST
TOST
Operating Cash FlowLast quarter
$95.0M
$194.0M
Free Cash FlowOCF − Capex
$32.0M
$178.0M
FCF MarginFCF / Revenue
1.6%
10.9%
Capex IntensityCapex / Revenue
3.2%
1.0%
Cash ConversionOCF / Net Profit
1.51×
1.92×
TTM Free Cash FlowTrailing 4 quarters
$-10.0M
$608.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SOLV
SOLV
TOST
TOST
Q4 25
$95.0M
$194.0M
Q3 25
$76.0M
$165.0M
Q2 25
$169.0M
$223.0M
Q1 25
$29.0M
$79.0M
Q4 24
$219.0M
$147.0M
Q3 24
$169.0M
$109.0M
Q2 24
$355.0M
$124.0M
Q1 24
$442.0M
$-20.0M
Free Cash Flow
SOLV
SOLV
TOST
TOST
Q4 25
$32.0M
$178.0M
Q3 25
$-21.0M
$153.0M
Q2 25
$59.0M
$208.0M
Q1 25
$-80.0M
$69.0M
Q4 24
$92.0M
$134.0M
Q3 24
$76.0M
$97.0M
Q2 24
$297.0M
$108.0M
Q1 24
$340.0M
$-33.0M
FCF Margin
SOLV
SOLV
TOST
TOST
Q4 25
1.6%
10.9%
Q3 25
-1.0%
9.4%
Q2 25
2.7%
13.4%
Q1 25
-3.9%
5.2%
Q4 24
4.4%
10.0%
Q3 24
3.7%
7.4%
Q2 24
14.3%
8.7%
Q1 24
16.9%
-3.1%
Capex Intensity
SOLV
SOLV
TOST
TOST
Q4 25
3.2%
1.0%
Q3 25
4.6%
0.7%
Q2 25
5.1%
1.0%
Q1 25
5.3%
0.7%
Q4 24
6.1%
1.0%
Q3 24
4.5%
0.9%
Q2 24
2.8%
1.3%
Q1 24
5.1%
1.2%
Cash Conversion
SOLV
SOLV
TOST
TOST
Q4 25
1.51×
1.92×
Q3 25
0.06×
1.57×
Q2 25
1.88×
2.79×
Q1 25
0.21×
1.41×
Q4 24
7.06×
4.59×
Q3 24
1.39×
1.95×
Q2 24
3.99×
8.86×
Q1 24
1.86×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SOLV
SOLV

Infection Prevention And Surgical Solutions$752.0M38%
Cost Of Software And Rentals$508.0M25%
Health Information Systems Segment$347.0M17%
Dental Solutions Segment$343.0M17%
Related Party$14.0M1%

TOST
TOST

Technology Service$1.3B82%
License$256.0M16%
Product And Professional Services$43.0M3%

Related Comparisons